In the evaluation of oncology services, the CHNA identifies that 15% of the population will be over 65 within the next five years. The CHNA also identifies that 50% of men and 33% of women are expected to develop cancer during their lifetime and that new cancer cases are expected to grow from 3,200 in the present year to 4,282 in five years (an increase of 34%). The assessment also identifies that that the existing facilities that prevent, diagnose and…
$226 million to improve cancer prevention, detection, treatment and research, and provide better patient care and support.…
Business Plans: To work closely with Government, health practitioners, researchers, cancer advocacy groups, charities and cancers sufferers to help eradicate cancer.…
Gushard, K. (2011, November). Local experts target cancer rates and deaths. Lake Tribune. Retrieved from http://Laketribune.com…
References: Adams L, Terry LL. (2009). Cancer Information Services. Accessed on October 19, 2009 on the World Wide Web:…
Chang, S., & Collie, C. L. (2009). The future of cancer prevention: will our workforce be ready? Cancer Epidemiology Biomarkers & Prevention, 18(9), 2348-2351.…
Crichton says there will be a bill to try and make the full benefit of the decoded genome available to us all and believes that it will return us to fuel innovation and common genetic heritage (442). Calfee says the patients and the research process are the beneficiaries because gene patents are working the way they are supposed to be and have been working for a couple of centuries and more (445). One way or another patenting genes affect our privates human genes we are born with, the money it will cost to have tests done on that specific gene if patented, and the scope of which we can do research to help find the best possible solutions, the question is, is gene patenting for the greater good of human beings or are we so money hungry we would rather be blind to…
“My hope is that we can have a lot of conversations around genomic information,” Flowers said. “I don’t think we know yet how to prepare healthcare providers for this massive onslaught of genomic information, or how to integrate it into our genomic practice, but my goal was just to start the dialogue and start moving the path forward.”…
Individuals interested in the field of health information technology (HIT) are presented with a vast array of HIT related jobs and professions to choose from, many of which are highly specialized, such as the certified tumor registrar (CTR). A cancer registry is a compilation of all cancer related data on all cancer patients, including their demographics, medical histories, diagnostic findings, and follow up assessments. This information provides health care professionals with the necessary data and tools to successfully develop, implement, assess and evaluate current and future treatments and therapies for the overall goal of preventing and controlling cancer (NCRA, 2002). The registry is also a key tool in providing necessary data to present statistical analysis regarding prevalence, success rates, morbidity and mortality rates for each type of cancer and is critical in aiding in research for etiology and prevention (German et al., 2008).…
For years, Katie Couric and other public figures have emphasized the importance of colon cancer screening, urging Americans to get screened since this is one of the few cancers that can be prevented. These communication efforts have broken the silence on both colonoscopies and colon cancer, helping erase the stigma around the screening process. Research on the genomics of cancer, colon cancer being an example, has taught us that the information within the biology of the tumor is crucial to understanding how it will behave and progress.…
Ruth Chadwick, the author of “Drug Discovery Today: Therapeutic Strategies”, revealed her concerns for the personalized medicine movement, “The move towards personalized medicine may disadvantage some patients in some social contexts, by shifting the allocation of resources in the health care system. Risks also surround the increasing accumulation of health data that goes hand in hand with personalized medicine” (Chadwick 171). Chadwick refers to the collection of personal DNA test information, “accumulation of healthcare data” as a risk; however, with the increased informational knowledge brought in by personalized medicine testing, cancer or other incurable diseases could benefit from an increased database of information. The risks mentioned by Chadwick may elude to an ethical argument for the increased concerns as personalized medicine comes to mainstream healthcare. Ideally, the increase in genetic testing among individuals through the implementation of personalized medicine would bring in massive amounts of information regarding the precursors for diseases and cancer allowing medical attention to become more accurate.…
As we all know Fighting Cancer is a big deal to our society it’s a sickness that ought to get rid of. Statistics shows how many people are diagnosed and killed by this disease yearly…
Genomics is changing healthcare as we know it. Prevention plays a key role in nursing practice, making it obvious as to why genomics has and will continue to be such a vital component in patient care. Medical history is a great indicator of risk factors for patients, this includes family history (inherited genes), and social history (lifestyle choices); incorporation of the environment and how a person’s genes react to stressors are also indicative of risk factors. One area of focus in this paper will be the identification of the BRCA 1/2 gene mutation through genetic testing, and its profound impact on the prevention, prognosis, diagnosis, and treatment of breast cancer for women. The objective that will be emphasized throughout this paper comes from Healthy People 2020 (2012), and it is “to increase the proportion of women with a family history of breast and/or ovarian cancer who receive genetic counseling”. In accordance to this objective, women with BRCA1/2 mutations that choose to have surgery, can reduce the risk of ovarian and breast cancer by 85 percent or more (Healthy People 2020, 2012). Core Functions…
When using genetic technology in personalized medicine is that some patients may receive incorrect information about their disease risk. This will bring up liability issue for them providing and prescribing the wrong preventive drug that may cause the individual to have severe to fatal side effects. The information can be falsely given but the patient has the burden of proof when it comes to filling a claim for negligence. This genetic testing that would lead to personalized medicine also causes the potential risk of stress on a patient when you put the thought into their heads that they may contract a certain disease that may be life threatening. There are many other drawbacks. The question of how accurate the tests are comes into play, being that there is no accuracy measurement in place for most. When given the results “Say you are tested for the potential for lung cancer, and learn that you might develop it someday. You decide not to smoke and you don’t develop it. But you can’t now know whether the test was right or wrong to begin with because you took steps not to develop it.”(Torrey, 2010) You also need someone who is trained in translating the results for you. Also your privacy is really not yours because you’re DNA can also be like your social and be kept, sold, and they even may us it however they see fit for their personal gain. The HIPPA laws don’t cover genetic testing so you’re not protected at all. The main drawback right now is that they aren’t effective enough in the early stages of the development. In the future with more test and better laws in place Genetic testing will make the personalized healthcare business…
Source: Surveillance, Epidemiology, and End Results Program, 1975-2003, Div. of Cancer Control and Pop. Sciences, NCI, 2006…